Genomic Health, Inc. announced earnings results for the second quarter ended June 30, 2019. For the second quarter, the company announced total revenue was USD 114.140 million compared to USD 95.619 million a year ago. Operating income was USD 15.498 million compared to USD 7.100 million a year ago. Net income was USD 15.987 million compared to USD 8.317 million a year ago. Basic earnings per share was USD 0.43 compared to USD 0.23 a year ago. Diluted earnings per share was USD 0.42 compared to USD 0.23 a year ago. For the half year, total revenue was USD 222.909 million compared to USD 188.244 million a year ago. Operating income was USD 27.038 million compared to USD 2.712 million a year ago. Net income was USD 28.986 million compared to USD 4.542 million a year ago. Basic earnings per share was USD 0.79 compared to USD 0.13 a year ago. Diluted earnings per share was USD 0.75 compared to USD 0.12 a year ago.